Food and Drug Administration
Pediatric Subcommittee
October 29-30, 2003
Briefing Information
Table of Contents (HTM) (PDF) (Word)
Cover Memorandum - Overview (HTM) (PDF) (Word)
Clobex Lotion Label (PDF)
Cutivate® Cream Label (PDF)
Diprolene® AF Cream Label (PDF)
Diprosone® Cream, USP Label (PDF)
Diprosone® Lotion, USP Label (PDF)
Diprosone® Ointment, USP Label (PDF)
Elocon® Cream Label (PDF)
Elocon® Lotion Label (PDF)
Elocon® Ointment Label (PDF)
Lotrtisone® Cream and Lotion (PDF)
Olux® Foam Label (PDF)
Temovate® Cream and Ointment Label (PDF)
Temovate E® Emollient Label (PDF)
Westcort® Cream Label (PDF)
Elidel Cream Approval Letter (PDF)
Elidel® Cream Label (PDF)
Protopic Ointment Appplication Letter (PDF)
Protopic® Ointment Label (PDF)
Memorandum Regarding Postmarketing Safety Review--PID D010141, Dr. Joyce Weaver, PharmD, FDA (HTM) (PDF) (Word)
Memorandum Regarding Safety Review--PID D030565, Dr. Claudia Karwoski, PharmD, FDA (HTM) (PDF) (Word)
Zyrtec® Tablets and Syrup (PDF)